Elon Musk indicated he would take steps to ease tensions with U.S. President Donald Trump, following a public feud that ...

GoodRx is a compelling small-cap value play with stabilizing growth, expanding pharma partnerships, and potential acquisition ...

Shoe Carnival's strong balance sheet, low payout ratio, and robust free cash flow ensure dividend safety and future growth ...

TPG RE Finance Trust (TRTX) is a strong buy with its 12.4% dividend yield, 31% discount to book value, and robust liquidity.

GFLW's FCF-focused strategy, impressive AUM growth, and quality-heavy factor mix make it a Buy despite its growth-exposure ...

Intapp's vertical SaaS focus delivers high retention, robust growth, and structural strengths. Read here to know why we ...

Recent research from economists at Atlanta Fed suggests that if firms are able to pass through all the costs of tariffs, ...

The Chinese authorities summoned major electric vehicle manufacturers, including BYD, urging them to self-regulate as the ...

FTXR ETF revamped its strategy with a focus on auto stocks, but growth remains uncertain. Read more on the ETF's potential ...

Amgen faces major revenue risk from upcoming patent cliffs but has promising pipeline drugs to offset losses. Learn why AMGN ...

THOR Industries saw revenue growth & profitability in Q325. Strong RV demand, solid liquidity, and rebound trends make THO ...

For Q1 of 2025, globally announced M&A activity totaled $885 billion, a 15% increase relative to Q1 of 2024. Click here to ...